Terms: = Bone cancer AND BRAF, MGC126806, 673, ENSG00000157764, MGC138284, RAFB1, P15056, B-raf 1, BRAF1, B-raf1
433 results:
1. Decabromodiphenyl ether exposure reduces dabrafenib sensitivity of papillary thyroid carcinoma harboring braf
Wang X; Cui X; Wang Y; Wang Q; Sun F; Liu Z
Toxicology; 2024 May; 504():153807. PubMed ID: 38641160
[TBL] [Abstract] [Full Text] [Related]
2. [Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
[No Abstract] [Full Text] [Related]
3. Splenic B-cell lymphoma/leukemia with prominent nucleoli: A three-case series of the newly named old entity and review of literature.
Rai V; Saha A; Gondha S; Manimaran P; Sawhney J
J Cancer Res Ther; 2024 Jan; 20(1):315-320. PubMed ID: 38554340
[TBL] [Abstract] [Full Text] [Related]
4. Comparative Analyses of Targeted Myeloid cancer Next-Generation Sequencing Panel in Fresh Blood, bone Marrow and FFPE Material.
Hobeck AD; Wendt S; Krohn S; Knuebel G; Bartels S; Schipper E; Junghanss C; Murua Escobar H
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542506
[TBL] [Abstract] [Full Text] [Related]
5. Hairy cell leukemia 2024: Update on diagnosis, risk-stratification, and treatment-Annual updates in hematological malignancies.
Troussard X; Maître E; Paillassa J
Am J Hematol; 2024 Apr; 99(4):679-696. PubMed ID: 38440808
[TBL] [Abstract] [Full Text] [Related]
6. Mosaic RASopathies concept: different skin lesions, same systemic manifestations?
Morren MA; Fodstad H; Brems H; Bedoni N; Guenova E; Jacot-Guillarmod M; Busiah K; Giuliano F; Gilliet M; Atallah I
J Med Genet; 2024 Apr; 61(5):411-419. PubMed ID: 38290824
[TBL] [Abstract] [Full Text] [Related]
7. Efficacy and safety of 'Second Adjuvant' therapy with braf/MEK inhibitors after local therapy for recurrent melanoma following adjuvant PD-1 based immunotherapy.
Taylor AM; McKeown J; Dimitriou F; Jacques SK; Zimmer L; Allayous C; Yeoh HL; Haydon A; Ressler JM; Galea C; Woodford R; Kahler K; Hauschild A; Festino L; Hoeller C; Schwarze JK; Neyns B; Wicky A; Michielin O; Placzke J; Rutkowski P; Johnson DB; Lebbe C; Dummer R; Ascierto PA; Lo S; Long GV; Carlino MS; Menzies AM
Eur J Cancer; 2024 Mar; 199():113561. PubMed ID: 38278009
[TBL] [Abstract] [Full Text] [Related]
8. Metastatic Undifferentiated Melanoma Mimicking a Primary bone Tumor: A Potential Diagnostic Pitfall.
Wills A; Dibbern M; Frierson HF; Raghavan SS
Am J Dermatopathol; 2024 Mar; 46(3):170-172. PubMed ID: 38170737
[TBL] [Abstract] [Full Text] [Related]
9. Sequential immunotherapy and targeted therapy for metastatic braf V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial.
Ascierto PA; Casula M; Bulgarelli J; Pisano M; Piccinini C; Piccin L; Cossu A; Mandalà M; Ferrucci PF; Guidoboni M; Rutkowski P; Ferraresi V; Arance A; Guida M; Maiello E; Gogas H; Richtig E; Fierro MT; Lebbe C; Helgadottir H; Queirolo P; Spagnolo F; Tucci M; Del Vecchio M; Cao MG; Minisini AM; De Placido S; Sanmamed MF; Mallardo D; Paone M; Vitale MG; Melero I; Grimaldi AM; Giannarelli D; Dummer R; Sileni VC; Palmieri G
Nat Commun; 2024 Jan; 15(1):146. PubMed ID: 38167503
[TBL] [Abstract] [Full Text] [Related]
10. Dabrafenib plus trametinib in unselected advanced braf V600-mut melanoma: a non-interventional, multicenter, prospective trial.
Richtig E; Nguyen VA; Koelblinger P; Wolf I; Kehrer H; Saxinger W; Ressler JM; Weinlich G; Meyersburg D; Hafner C; Jecel-Grill E; Kofler J; Lange-Asschenfeldt B; Weihsengruber F; Rappersberger K; Svastics N; Gasser K; Seeber A; Kratochvill F; Nagler S; Mraz B; Hoeller C
Melanoma Res; 2024 Apr; 34(2):142-151. PubMed ID: 38092013
[TBL] [Abstract] [Full Text] [Related]
11. Clinical Predictors of Survival in Patients With brafV600-Mutated Metastatic Melanoma Treated With Combined braf and MEK Inhibitors After Immune Checkpoint Inhibitors.
Kahn AM; Perry CJ; Etts K; Kluger H; Sznol M
Oncologist; 2024 Apr; 29(4):e507-e513. PubMed ID: 37971411
[TBL] [Abstract] [Full Text] [Related]
12. Neoadjuvant braf-targeted therapy for ameloblastoma of the mandible: an organ preservation approach.
Grynberg S; Vered M; Shapira-Frommer R; Asher N; Ben-Betzalel G; Stoff R; Steinberg Y; Amariglio N; Greenberg G; Barshack I; Toren A; Yahalom R; Schachter J; Rechavi G; Hirschhorn A; Abebe Campino G
J Natl Cancer Inst; 2024 Apr; 116(4):539-546. PubMed ID: 37966914
[TBL] [Abstract] [Full Text] [Related]
13. A visualized model for identifying optimal candidates for aggressive locoregional surgical treatment in patients with bone metastases from breast cancer.
Tong Y; Xu S; Jiang L; Zhao C; Zhao D
Front Endocrinol (Lausanne); 2023; 14():1266679. PubMed ID: 37867528
[TBL] [Abstract] [Full Text] [Related]
14. Current concepts in targeted therapies for benign tumors of the jaw - A review of the literature.
Graillon N; Akintoye SO; Iocca O; Kaleem A; Hajjar S; Imanguli M; Shanti RM
J Craniomaxillofac Surg; 2023 Oct; 51(10):591-596. PubMed ID: 37852890
[TBL] [Abstract] [Full Text] [Related]
15. Treatment options for advanced ameloblastoma in the era of precision medicine: A brief review.
Oh KY
Oral Oncol; 2023 Nov; 146():106585. PubMed ID: 37816291
[TBL] [Abstract] [Full Text] [Related]
16. Kinase fusion positive intra-osseous spindle cell tumors: A series of eight cases with review of the literature.
Suurmeijer AJH; Xu B; Torrence D; Dickson BC; Antonescu CR
Genes Chromosomes Cancer; 2024 Jan; 63(1):e23205. PubMed ID: 37782551
[TBL] [Abstract] [Full Text] [Related]
17. Genetic Aspects of Conjunctival Melanoma: A Review.
Chang E; Demirci H; Demirci FY
Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761808
[TBL] [Abstract] [Full Text] [Related]
18. [Histological Classification and Diagnosis of Sellar/Parasellar Tumors].
Nishioka H
No Shinkei Geka; 2023 Sep; 51(5):789-798. PubMed ID: 37743330
[TBL] [Abstract] [Full Text] [Related]
19. Osteosarcoma's genetic landscape painted by genes' mutations.
Urban W; Krzystańska D; Piekarz M; Nazar J; Jankowska A
Acta Biochim Pol; 2023 Sep; 70(3):671-678. PubMed ID: 37717265
[TBL] [Abstract] [Full Text] [Related]
20. The Prognostic Impact of Preoperative Osteopenia in Patients With Colorectal cancer.
Kato H; Seishima R; Mizuno S; Matsui S; Shigeta K; Okabayashi K; Kitagawa Y
Dis Colon Rectum; 2023 Dec; 66(12):e1225-e1233. PubMed ID: 37699124
[TBL] [Abstract] [Full Text] [Related]
[Next]
